LAUREN JARRELL: Open Payments
NPI 1952823635 · WASHINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 11 payments from 7 companies in 2025. Trend: 2023 $168 · 2024 $475 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 4 | $185 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Xhance, DUPIXENT, BOTOX, Ryaltris, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
